Genus (GNS)

Sector:

Pharma and Biotech

Index:

FTSE 250

2,030.00p
   
  • Change Today:
      32.00p
  • 52 Week High: 2,155.00
  • 52 Week Low: 1,424.00
  • Currency: UK Pounds
  • Shares Issued: 66.04m
  • Volume: 214,697
  • Market Cap: £1,340.55m
  • RiskGrade: 128
  • Beta: 0.05

Dividends

Year End Type Amount Payment Date Ex-Div Date Record Date
30-Jun-20 Interim 9.40p 02-Apr-20 05-Mar-20 06-Mar-20
  Final 19.70p 11-Dec-20 19-Nov-20 20-Nov-20
30-Jun-21 Interim 10.30p 01-Apr-21 04-Mar-21 05-Mar-21
  Final 21.70p 10-Dec-21 18-Nov-21 19-Nov-21
30-Jun-22 Interim 10.30p 31-Mar-22 03-Mar-22 04-Mar-22
  Final 21.70p 09-Dec-22 17-Nov-22 18-Nov-22
30-Jun-23 Interim 10.30p 30-Mar-23 02-Mar-23 03-Mar-23
  Final 21.70p 08-Dec-23 09-Nov-23 10-Nov-23
30-Jun-24 Interim 10.30p 28-Mar-24 29-Feb-24 01-Mar-24
  Final 21.70p 06-Dec-24 07-Nov-24 08-Nov-24
30-Jun-25 Interim 10.30p 04-Apr-25 06-Mar-25 07-Mar-25

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Historical interim dividends and record dates not previously collected

Note 4: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Genus Market Data

Currency UK Pounds
Share Price 2,030.00p
Change Today 32.00p
% Change 1.60 %
52 Week High 2,155.00
52 Week Low 1,424.00
Volume 214,697
Shares Issued 66.04m
Market Cap £1,340.55m
Beta 0.05
RiskGrade 128

Genus Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
88.96% below the market average88.96% below the market average88.96% below the market average88.96% below the market average88.96% below the market average
87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average
Price Trend
45.45% above the market average45.45% above the market average45.45% above the market average45.45% above the market average45.45% above the market average
74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average74.47% above the sector average
Income
92.91% below the market average92.91% below the market average92.91% below the market average92.91% below the market average92.91% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
92.35% below the market average92.35% below the market average92.35% below the market average92.35% below the market average92.35% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 6
Buy 3
Neutral 1
Sell 0
Strong Sell 0
Total 10
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Genus Dividends

  Latest Previous
  Interim Final
Ex-Div 06-Mar-25 07-Nov-24
Paid 04-Apr-25 06-Dec-24
Amount 10.30p 21.70p

Trades for 23-May-2025

Time Volume / Share Price
16:35 150 @ 2,030.00p
16:20 40 @ 2,010.00p
16:20 46 @ 2,007.50p
16:02 4 @ 2,005.00p
16:02 30 @ 2,010.00p

Genus Key Personnel

CFO Alison Henriksen
CEO Jorgen Kokke

Top of Page